CATALYST BIOSCIENCES INC's ticker is CBIO and the CUSIP is 14888D208. A total of 65 filers reported holding CATALYST BIOSCIENCES INC in Q4 2018. The put-call ratio across all filers is 0.75 and the average weighting 0.1%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 547,541 | $3,214,000 | 6.22% |
| ACUTA CAPITAL PARTNERS, LLC | 1,497,900 | $8,793,000 | 2.54% |
| 22NW, LP | 735,841 | $4,319,000 | 2.34% |
| Prosight Management, LP | 248,050 | $1,456,000 | 0.62% |
| Worth Venture Partners, LLC | 127,983 | $751,000 | 0.37% |
| Parkman Healthcare Partners LLC | 215,237 | $1,263,000 | 0.36% |
| Sio Capital Management, LLC | 198,714 | $1,166,000 | 0.34% |
| Amtrust Financial Services, Inc. | 50,000 | $294,000 | 0.32% |
| Nantahala Capital Management | 1,821,749 | $10,694,000 | 0.32% |
| Essex Woodlands Management, Inc. | 78,622 | $462,000 | 0.23% |